Community/Retail

The American Pharmacists Association (APhA) Foundation today announced 20 recipients of its 2017 Incentive Grants for Practitioner Innovation in Pharmaceutical Care.

The FDA has approved Endoceutics' prasterone (Intrarosa), a once-daily vaginal insert for the treatment of women who experience moderate to severe pain during sexual intercourse as a result of menopause.

Human papilloma virus (HPV) causes about 31,000 cancers in women and men (and 4,000 deaths in women) annually.

Janssen has entered a clinical trial collaboration and supply agreement with Onyx to evaluate the efficacy and safety of Darzalex, the first-in-class CD38-directed immunotherapy daratumumab, in combination with a proteasome inhibitor carfilzomib and dexamethasone.

Buprenorphine is one of the most commonly prescribed medications to treat opioid addiction. In 2014, about 60-65% of Americans using medication-assisted treatment received buprenorphine. On July 6, 2016, the Department of Health and Human Services (HHS) announced that it will raise the limit on the number of patients that can receive the addiction medicine buprenorphine to 275 patients per qualified provider. This article describes potential monetary conflicts in proving buprenorphine, how increased access will affect pharmacists and what they can do to help patients in need of medication supported abstinence and substance abuse counseling.

Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients?

How green is your pharmacy? Think about how much you and your coworkers are reducing, reusing, and recycling in the pharmacy.

A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira).

New MinuteClinic walk-in medical clinics have opened inside CVS Pharmacy stores in the Middle Village neighborhood in Queens and in Brooklyn.

Baptist Health and Walgreens have announced a collaboration focused on improving and coordinating healthcare to create greater convenience and value for residents of northeast Florida.

Two pharmacists are being accused for their roles in a long-running, illegal prescription pain medication distribution conspiracy.

The FDA has approved Opdivo (nivolumab) by Bristol-Myers Squibb for the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

The synthetic drug U-47700 is dangerous and is considered a major threat to public health and safety.

In pharmacy school, I was taught to see if there was a cause when I learned of a patient?s adverse reaction, because if I?m treating the problem without removing the cause, the problem will still persist. In this situation, I couldn?t remove the cause. If I were to request that the doctor stop prescribing the calcium supplements, the elderly patient would be at higher risk for osteoporosis. If I can?t remove the cause, what can I do in this type of situation?

The American Pharmacists Association (APhA) has released a video commemorating the 20th anniversary of its Pharmacy-based Immunization Certificate Training Program and the important role pharmacists are playing within the “immunization neighborhood,” which involves the collaboration, coordination, and communication among immunization stakeholders.

Poor medication adherence contributes to 125,000 deaths annually, causes up to half of all treatment failures, and costs the US healthcare system $100 billion each year.

Adolescent females need a wide variety of nutrients for proper development, especially bone health. Neither plant-based food (even if protein-rich) nor dairy products alone provide the necessary range of nutrients.

The FDA has approved Vemlidy (tenofovir alafenamide) from Gilead for the treatment of chronic hepatitis B infection with compensated liver disease.

Human papillomavirus (HPV) causes 30,700 cervical, anal, oropharyngeal, penile, and vaginal/vulvar cancer cases annually. Multiple vaccines are available to combat at least the main oncogenic strains 16 and 18 that cause 90% of cancer cases.

Judith A. Monroe, M.D., FAAFP, president and CEO of the Centers for Disease Control and Prevention (CDC) Foundation, will accept the 2016 NACDS Foundation Excellence in Patient Care Award at the NACDS Foundation Dinner on December 1, 2016, in New York City.

Rite Aid stores nationwide are now able to offer American Express Card Members participating in the Membership Rewards program the opportunity to use Membership Rewards points for eligible purchases.

The American Cancer Society and the CVS Health Foundation have awarded grants to 20 US colleges and universities as part of their Tobacco-Free Generation Campus Initiative, a $3.6 million multi-year program intended to accelerate and expand the adoption and implementation of 100 percent smoke- and tobacco-free campus policies.

A New York pharmacist was convicted of narcotics and health care fraud charges on Thursday, November 10.

A study published in JAMA Psychiatry has concluded that infants born to mothers who use selective serotonin reuptake inhibitors (SSRIs) during pregnancy are at higher risk for speech and language disorders during childhood.

Revance has begun its phase 2 placebo-controlled trial for DaxibotulinumtoxinA (RT002) for injection.

The CDC has recently reported increasing antibiotic resistant Treponema pallidum strains and ocular syphilis incidence.

Vietnam War veterans are more likely to contract hepatitis C virus than any other veterans, and 65-year-old Joe Benko was no exception to the statistic.

The Kroger Co. has announced a total contribution to the USO of nearly $3.1 million for 2016, including a company contribution of $1 million in funds.